循环microRNA与急性缺血性卒中患者3个月结局相关
在巴塞罗那Hospital del Mar医院2009至2018年纳入的215例急性缺血性卒中患者中,进行血浆microRNA二代测序差异表达分析,发现74个microRNA与3个月不良结局显著相关;在另一个多中心队列191例患者中验证26个候选microRNA,其中5个重复出与不良结局的关联。
要点
- 发现阶段74个microRNA与3个月不良结局显著相关(Q<0.05)。
- 验证阶段5个microRNA重复出与不良结局的关联(p<0.05,倍数变化>1.7)。
- 这5个microRNA在3个月不良结局患者中过表达,可能参与认知、神经元形态发生和TGF-β反应等生物学过程。
核心结论
- 研究识别出5个在缺血性卒中后3个月不良结局患者中过表达的microRNA,可能参与认知、神经元形态发生和转化生长因子β(TGF-β)反应等生物学过程,提示其在脑恢复中的潜在作用。
- 这些发现未在幕下卒中和腔隙性卒中中评估,限制了在这些特定亚型中的推广性。
- 需要进一步研究探索这些发现的潜在适用性。
研究设计与样本
- 发现研究在西班牙巴塞罗那Hospital del Mar医院2009至2018年收治的急性缺血性卒中患者中进行,主要纳入标准为初始NIH卒中量表(NIHSS)评分>2、卒中发病24小时内入院、既往功能独立。
- 对发病24小时内获取的血浆样本进行microRNA二代测序,使用DESeq2软件包对2,083个microRNA进行差异表达分析。
- 验证阶段在另一个多中心队列中使用实时PCR进行,纳入标准相同,并采用多变量回归模型。
- 两个阶段均进行富集通路分析。
主要发现
- 发现队列纳入215例缺血性卒中患者(平均年龄74.7±10.2岁,54.9%为男性),年龄、性别和卒中严重程度(采用24小时NIHSS测量)与3个月结局相关(p<0.05)。
- 调整这些潜在混杂因素后,发现74个microRNA与3个月不良结局显著相关(Q<0.05)。
- 通路分析显示与血管生成、神经元形态发生、转化生长因子β(TGF-β)、内皮发育和认知相关通路存在显著关联。
- 验证队列纳入191例患者(平均年龄78.0±6.0岁,49.7%为男性),分析从发现阶段选出的26个microRNA,其中5个重复出与不良结局的关联(p<0.05,倍数变化>1.7):miR-376c-3p、miR-4463、miR-199a-3p、miR-584-5p和miR-134-5p。
关键数值与推荐
- 不良3个月结局定义为改良Rankin量表评分>2。
- 发现阶段差异表达分析阈值:Q<0.05。
- 验证阶段重复出关联的阈值:p<0.05且倍数变化>1.7。
局限性
- 这些发现未在幕下卒中和腔隙性卒中中评估,限制了在这些特定亚型中的推广性。
- 需要进一步研究探索这些发现的潜在适用性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Post-ischemic stroke (IS) outcomes vary widely among individuals, independently of clinical factors. This variability could be related to epigenetic mechanisms that regulate biological processes involved in recovery after ischemia. While several microRNAs (miRNAs) and their target genes are implicated in the pathophysiology of IS, their role in functional outcomes remains unclear. Our aim is to identify potential miRNAs associated with the 3-month outcome in patients with IS. METHODS: A discovery study was performed in patients with acute IS assessed at Hospital del Mar of Barcelona from 2009 to 2018. Main inclusion criteria were initial NIH Stroke Scale (NIHSS) score >2, hospital admission within 24 hours of IS onset, and previous functional independence. Poor 3-month outcome was defined as a modified Rankin Scale score >2. We performed miRNA next-generation sequencing on plasma samples obtained within 24 hours and performed a differential expression analysis for 2,083 miRNAs using the DESeq2 package. A replication stage was performed using real time-PCR in another multicenter cohort, with equivalent inclusion criteria and multivariate regression models. We also performed enrichment pathways analyses in both phases. RESULTS: The discovery cohort included 215 patients with IS (mean age 74.7 ± 10.2 years, 54.9% male). Age, sex, and stroke severity (measured with the 24-hour NIHSS) were associated with the 3-month outcome (p < 0.05). After adjusting for these potential confounders, we found 74 miRNAs significantly associated (Q < 0.05) with the 3-month poor outcome. Pathway analysis revealed significant associations with pathways related to angiogenesis, neuronal morphogenesis, transforming growth factor β (TGF-β), endothelial development, and cognition. The replication included 191 patients (mean age 78.0 ± 6.0 years, 49.7% male). We analyzed 26 miRNAs selected from the discovery stage, and 5 miRNAs replicated their association with poor outcomes (p < 0.05, fold change >1.7): miR-376c-3p, miR-4463, miR-199a-3p, miR-584-5p, and miR-134-5p. DISCUSSION: We identified 5 miRNAs overexpressed in patients with poor 3-month outcomes after IS, which could be involved in biological processes such as cognition, neuronal morphogenesis, and TGF-β response, suggesting a potential role in brain recovery. These findings were not evaluated in infratentorial and lacunar strokes, which limits generalizability in these particular subtypes. Further investigation is needed to explore potential applicability of these findings.
引用
- Fernández-Pérez I, Vallverdú-Prats M, Rey-Álvarez L, et al. Circulating miRNAs Associated With 3-Month Outcome in Patients With Acute Ischemic Stroke. Neurology. 2024. PMID: 39652811. doi:10.1212/WNL.0000000000210085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。